Literature DB >> 24117612

Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sjögren's syndrome.

R Belkhir1, N Gestermann, M Koutero, R Seror, J Tost, X Mariette, C Miceli-Richard.   

Abstract

Epigenetic deregulation of genes encoded on the X chromosome as reported for CD40L in lupus could explain the female predominance of autoimmune diseases. We compared CD40L expression on CD4(+) T cells from primary Sjögren's syndrome (pSS) women and healthy controls and investigated DNA methylation patterns of the promoter and enhancer regions of CD40L. The expression of CD40L on activated CD4(+) T cells was higher in patients with pSS than controls after phorbolmyristate acetate and ionomycin activation (P = 0.02). CD40L mRNA level in CD4(+) T cells did not differ between patients with pSS and controls and was similar in both groups in cultures treated with the demethylating agent 5-azacytidine C. Pyrosequencing analysis revealed no significant differences in methylation profiles between patients and controls. Inducible membrane-bound CD40L on CD4(+) T cells is increased in patients with pSS but was not related to epigenetic deregulation by demethylation patterns of the regulatory regions of CD40L.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24117612     DOI: 10.1111/sji.12121

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

Review 1.  Biologic therapy in Sjögren's syndrome.

Authors:  Qin Shao
Journal:  Clin Rheumatol       Date:  2020-10-27       Impact factor: 2.980

Review 2.  Current and future therapies for primary Sjögren syndrome.

Authors:  Raphaèle Seror; Gaetane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2021-06-29       Impact factor: 20.543

Review 3.  The contribution of epigenetics in Sjögren's Syndrome.

Authors:  Orsia D Konsta; Yosra Thabet; Christelle Le Dantec; Wesley H Brooks; Athanasios G Tzioufas; Jacques-Olivier Pers; Yves Renaudineau
Journal:  Front Genet       Date:  2014-04-03       Impact factor: 4.599

4.  Effect of mesenchymal stem cells on Sjögren-like mice and the microRNA expression profiles of splenic CD4+ T cells.

Authors:  Guang-Feng Ruan; Ling Zheng; Jia-Shu Huang; Wan-Xue Huang; Bang-Dong Gong; Xing-Xing Fang; Xiao-Yu Zhang; Jian-Ping Tang
Journal:  Exp Ther Med       Date:  2017-04-06       Impact factor: 2.447

Review 5.  Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment.

Authors:  Tim Both; Virgil A S H Dalm; P Martin van Hagen; Paul L A van Daele
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

6.  HIF1A (rs11549465) and AKNA (rs10817595) Gene Polymorphisms Are Associated with Primary Sjögren's Syndrome.

Authors:  Gabriela Hernández-Molina; José Manuel Rodríguez-Pérez; Javier Fernández-Torres; Guadalupe Lima; Nonanzit Pérez-Hernández; Alberto López-Reyes; Gabriela Angélica Martínez-Nava
Journal:  Biomed Res Int       Date:  2017-04-06       Impact factor: 3.411

Review 7.  Immune Monitoring upon Treatment with Biologics in Sjögren's Syndrome: The What, Where, When, and How.

Authors:  Joyce J B C van Beers; Jan G M C Damoiseaux
Journal:  Biomolecules       Date:  2021-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.